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Summary.-The effect of an antiserum containing antibodies against cell surface
components of PyBHK cells on the action of certain anticancer agents has been
studied using a colony formation inhibition assay. The effects of x-rays, chlor-
ambucil, CCNU and possibly ICRF 159 are augmented by the antiserum whereas
methotrexate and vinblastine are not.
THE AUGMENTATION of the action of
some cytotoxic drugs, as well as x-rays,
by antibody directed against the surface
of the target cell has been reported
(Davies, Buckham and Manstone, 1974;
Ghose and Cerini, 1969; Rubens and
Dulbecco, 1974) and reviewed (Rubens,
1974). The augmentation effect is of
potential interest in chemotherapy since
it may be possible to increase the specifi-
city of anticancer agents. However, the
mechanism of this augmentation by anti-
body is still not understood. In this
article, we report on experiments in which
the spectrum of potentiation has been
explored further, using the same in vitro
system as in a previous study (Rubens
and Dulbecco, 1974). In this way it was
possible to compare the augmentation of
different agents under similar conditions.
MATERIALS AND METHODS
The target cells for these experiments
were polyoma-transformed BHK21/C13 cells
(J1) grown in Dulbecco's modified Eagle's
medium supplemented with 10% calf serum
which had been heated to 56°C for 30 min to
inactivate complement. The cells ofgrowing
cultures were collected using a Tris-buffered
saline containing 0-02% versene. An anti-
serum to these cells was produced in New
Zealand white rabbits. Each rabbit received
approximately 1 x 108 intact cells intra-
muscularly twice weekly for 4 weeks. The
resulting antiserum (immune rabbit serum,
IRS) contained antibodies for surface com-
ponents of J1 cells. At dilution 1: 5 it
resulted in the appearance of membrane
immunofluorescence by the indirect method
using fluorescein labelled sheep anti-rabbit
globulin (Miles-Serevac) in essentially all
exposed J1 cells. The antiserum was also
cytotoxic for J1 cells in the presence of
guinea-pig complement (Wellcome), as shown
by isotope release from cells prelabelled with
radioactive chromium (51Cr); 50% of cells
were lysed at a 1 320 dilution. Control
normal rabbit serum (NRS) was obtained by
bleeding the rabbits before immunization.
Both the normal and the immune serum were
heat inactivated, sterilized through a 0-22 ,um
Millipore filter and stored at -20°C until
used. The following drugs were used: (a)
chlorambucil B.P. (Wellcome) prepared
immediately before use by dissolving in
0-5 mol/l sodium bicarbonate at room temper-
ature andthendiluting immediately with cold
phosphate-buffered saline solution (PBS);
(b) 1-(2-chloroethyl)-3-cyclohexyl-1-nitro-
sourea (CCNU) (from Dr T. A. Connors)
preparedimmediately beforeusebydissolving
in dimethyl sulphoxide (DMSO) at 10 mg/ml
and then diluting as required in cold PBS;
the final concentration of DMSO in the
cultures was 0-1% or less; (c) (±)-1,2-bis(3,5-
dioxopiperazin-1-yl) propane (ICRF 159)
(from Dr A. M. Creighton) prepared by
dissolving in PBS; (d) methotrexate sodium
(Lederle) from a stock solution of 2-5/ml in
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normal saline (stored at 4°C) by diluting with
PBS; (e) vinblastine (Eli Lilly) prepared by
dissolving in PBS.
A colony formation inhibition assay was
used to assess the effect of the drugs in the
presence of the antiserum. One hundred
PyBHK cells were plated in each 50 mm
plastic Petri dish in a 4-5 ml volume of
medium. Sets of cultures received the
following additions in various combinations:
(1) 0-25 ml of PBS alone or containing either
NRS or IRS to give the final dilution required
in the culture and (2) 0-25 ml ofPBS contain-
ing a drug to give the concentration required
in the culture. The cultures were then
incubated at 37°C in humidified incubators,
flushed with carbon dioxide and 8 days later
the medium was aspirated, the colonies
fixed with methanol, stained with 20%
Giemsa stain and counted.
To study the effect of IRS on the colony
formation inhibition of PyBHK cells by
x-irradiation, cells were plated at a density
of 150 in 5 ml volumes of medium containing
either NRS (1: 80) or IRS (1: 80) and were
incubated at 37°C. Two and a half hours
laterthe cultures wereirradiatedwith220kVp
x-rays (source to specimen distance 50 cm;
dose rate-48 rad/min for doses <80 rad,
133 rad/min for doses 3 100 rad). The
colonies were stained and counted after 7
days' incubation.
RESULTS
The augmentation of the action of
chlorambucil was similar to that pre-
viously reported. The effect was more
marked as the concentration of the drug
was increased and this effect was enhanced
at lower dilutions of IRS (Table I).
However, as in the previous study, in the
absence of chlorambucil the cloning effi-
ciency was not influenced by the presence
of IRS. The cytostatic effect of CCNU
was also augmented by IRS and there was
a slight augmentation of ICRF 159 which
was of probable significance (Table II).
In contrast, the action of methotrexate
was not so potentiated; instead at the
highly toxic concentration of 20 mg/ml
the presence of IRS or, particularly, NRS
in the cultures conferred some protection
against the drug's action (Table II). The
cytostatic action of vinblastine, too, was
antagonized by both NRS and IRS.
Inhibition of colony formation by
x-rays was found to be consistently
greater in the presence of IRS at doses of
80 rads or more (Table III).
DISCUSSION
This study shows that in the PyBHK
cell system the phenomenon of augmen-
tation ofanticancer activity by antibodies
directed at the cell surface is restricted
only to certain agents. It is pronounced
with x-rays, chlorambucil and CCNU, and
possibly ICRF 159, but not with metho-
trexate or vinblastine. The effect was
marginalwith ICRF 159. The mechanism
of action of antibody mediated augmen-
tation of cytotoxic agent action is
unknown. It has been noted, however,
that the agents that are augmented by
the antiserum, namely, x-rays, alkylating
agents, CCNU and ICRF 159, produce
TABLE I.-Cloning Efficiency ofPyBHK Cells in Cultures Receiving Additions ofEither
PBS or Chlorambucil andEitherPBS or IRS. (Means i s.d. ofColonies in Triplicate
Cultures)
IRS dilution
, ~~~~~~AA
1 :640 1 :320 1 :160 1 :80
71±10 82±11 83±9 3 66±19
79±17 70+10 67±5 8 49±1 2
60+4 4 59±6 1 51+5 5 37+11
48±1 5 29±3 1 48±10 19+3 5
21±1 7 14±6 2 13±8 5 54-4
Differences between
PBS and IRS (1: 80)
Not significant
P < 0.01
P < 0-05
P < 0-001
P < 0-05
Chlorambucil
concentration
(sg/ml)
0
0 5
1
2
4
PBS
75±13
75±5
67± 10
62±4
19±5
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TABLE II.-Cloning Efficiency ofPyBHK Cells in Cultures Receiving Additions ofEither
PBS or Drugs and Either PBS, NRS or IRS. (Means ± s.d. ofColonies in Replicate
Cultures)
Differences
Drug PBS NRS (1: 80) IRS (1: 80) NRS and IRS
PBS 57±3-5 57±5-7 59±7 8 Not significant
CCNU
0 5 ,ug/ml 46±12 51± 13 33± 14 Not significant
1 jug/ml 45±1 46±6.4 32±3-5 P < 0 05
2 jug/ml 52±12 44±4*1 17±4-2 P < 0 001
4 ,ug/ml 24±2-4 37±4 5 8±5-5 P < 0 01
ICRF 159
2 ,umol/I 50±18 57±1-4 52±9-2 Not significant
4 umol/l 50±6-4 53±3 5 45±2-1 Not significant
8 Esmol/I 39±0 7 37±3 5 23±2-8 P < 0 05
Methotrexate
0 5ng/ml 67±2-8 61±0 7 59±6-4 Not significant
1 ng/ml 54±2-1 61±2-1 52±5-7 Notsignificant
2 ng/ml 53±5- 7 54±2-1 57±8-4 Not significant
20 ng/ml <1 10±7-1 3-5±3-5 Notsignificant
Vinblastine
4 nmol/I 27+21 45±3 5 47±1-4 Not significant
8 nmol/l 7±2 - 8 33±2-1 32±9 2 Not significant
16 nmol/l 0 2-5±2-1 2-5±2-1 Not significant
TABLE III.-Colony Formation Inhibition ofPyBHK Cells by X-rays (150 Cells Plated)
in Cultures Containing Either NRS (1: 80) or IRS (1: 80). (Means j s.d. of Colonies
in Triplicate Cultures)
Colonies
X-ray dose NRS IRS
(rad) (1: 80) (1: 80) Differences
0 71±9 60410 Not significant
20 67±6-5 36±7-2 P < 0-02
40 55±8-5 33±9 5 Not significant
60 60±6-2 36±9-6 Not significant
80 56±3-2 19±3-5 P < 0.001
100 55±2-6 16±4-6 P < 0 01
200 33±3-5 12±3 P < 0.01
300 27±6-5 5±1-5 P< 0-02
400 16±4-2 6±2*6 P < 0 05
500 11±2-6 3±1 P< 0-02
characteristic multinucleation in certain
cultured cells while other cytotoxic drugs,
including antimetabolites and vinblastine,
do not (Stephens and Creighton, 1974).
This correlation may give a clue to the
mechanism of augmentation.
This work formed part ofan MD Thesis
(University of London, 1974). We
acknowledge gifts from the following:
Drs T. A. Connors (CCNU), F. C. Copp
(chlorambucil) and A. M. Creighton (ICRF
159).
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